A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension (NCT07142356)
A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multicenter Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to learn if the drug RT-001 works to reduce high blood pressure (hypertension) in adults. It will also learn about the safety of RTN-001. The main questions it aims to answer are: Does RTN-001 lower blood pressure in patients who have uncontrolled hypertension? What medical problems do participants have when taking RTN-001? Researchers will compare RTN-001 to a placebo (a look-alike substance that contains no drug) to see if RTN-001 works to treat uncontrolled hypertension. Participants will: Take RTN-001 or a placebo every day for 12 weeks Visit the clinic about once every 2 weeks for checkups and tests Keep a diary of their symptoms and all medications that they take including RTN-001
Who can join: Review the eligibility criteria below.
Location: Retension Clinical Site — Tucson, Arizona
Age range: 18 Years to 70 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (22 Sites)
- Retension Clinical Site — Tucson, Arizona
- Retension Clinical Site — San Jose, California
- Retension Clinical Site — West Hills, California
- Retension Clinical Site — Waterbury, Connecticut
- Retension Clinical Site — Orlando, Florida
- Retension Clinical Site — Port Orange, Florida
- Retension Clinical Site — Tampa, Florida
- Retension Clinical Site — Lawrenceville, Georgia
- Retension Clinical Site — Peachtree Corners, Georgia
- Retension Clincial Site — Boston, Massachusetts
- Retension Clinical Site — Las Vegas, Nevada
- Retension Clinical Site — Las Vegas, Nevada
- Retension Clinical Site — Asheboro, North Carolina
- Retension Clinical Site — Charlotte, North Carolina
- Retension Clinical Site — Monroe, North Carolina
- Retension Clinical Site — Cincinnati, Ohio
- Retension Clinical Site — Charleston, South Carolina
- Retension Clinical Site — Bellaire, Texas
- Retension Clinical Site — Dallas, Texas
- Retension Clincal Site — Plano, Texas
- Retension Clinical Site — San Antonio, Texas
- Retension Clinical Site — Vienna, Virginia
📞 Contact the Study Coordinator
Phone: (703) 624-2024
Email: info@retensionpharmaceuticals.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Uncontrolled Hypertension
- Sequential Multiple Assignment Randomized Trial to Reduce Food Insecurity — Winston-Salem, North Carolina
- Remote Hypertension Management for Black Patients — Winston-Salem, North Carolina
- Renal Pelvic Denervation Pilot Trial — Birmingham, Alabama
Explore by condition: All Uncontrolled Hypertension clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.